Our Pricing

Wegovy Stock UK: Order All Doses Now - In Stock Today

Published on: June 03, 2026

Finding reliable wegovy stock uk all doses has been challenging throughout 2024, but Cured Pharmacy maintains consistent availability from the 0.25mg starter dose through to the 2.4mg maintenance pen. Our UK-registered clinical team can assess your suitability and arrange discreet delivery, with prices starting from £79.00 — significantly lower than typical market rates.

Current Wegovy Stock UK Availability at Cured Pharmacy

All five Wegovy doses are currently in stock and available for immediate prescription following clinical assessment. This includes the 0.25mg and 0.5mg starter doses, the 1mg and 1.7mg escalation doses, and the 2.4mg maintenance dose. Unlike the widespread shortages experienced across UK pharmacies in 2023 and early 2024, we've secured reliable supply chains directly with licensed UK wholesalers [1].

Wegovy (semaglutide 2.4mg) received MHRA approval for chronic weight management in 2022 and has since become the most prescribed GLP-1 receptor agonist for weight loss in the UK [2]. The medication works by mimicking the GLP-1 hormone, which regulates appetite and food intake through receptors in the brain and digestive system.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing from our GPhC-registered premises (9012511), ensuring every Wegovy pen meets UK pharmaceutical standards. Stock levels are updated in real-time, and we notify patients immediately if any supply issues arise — though our procurement strategy has maintained uninterrupted availability since launch.

How Wegovy Semaglutide Works for Weight Loss

Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class and functions through multiple physiological pathways. It slows gastric emptying, meaning food remains in your stomach longer and you feel fuller after smaller portions. It also acts on appetite centres in the hypothalamus to reduce hunger signals and food cravings [3].

The STEP clinical trial programme demonstrated Wegovy's efficacy across diverse patient populations. In the pivotal STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks when combined with lifestyle modification — compared to 2.4% with placebo [3]. Approximately 50% of participants lost at least 15% of their starting weight, and nearly one-third lost 20% or more.

Wegovy requires gradual dose escalation to minimise gastrointestinal side effects. You'll start with 0.25mg weekly for four weeks, then increase monthly through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose at week 17. This titration schedule allows your body to adapt to semaglutide's effects whilst reducing nausea and other common initial reactions [1][2].

Expected Results and Realistic Timelines

Most patients notice reduced appetite within the first two weeks of starting Wegovy, though meaningful weight loss typically becomes apparent after 8-12 weeks. Clinical trials showed the most significant weight reduction occurred between weeks 20 and 60, with results plateauing around month 16 [3]. Individual responses vary considerably based on baseline weight, adherence to lifestyle modifications, and metabolic factors. Your UK prescriber will monitor your progress and may adjust your treatment plan if you haven't achieved at least 5% weight loss after 12 weeks on the maintenance dose, as recommended by NICE guidance.

Wegovy Dosing Schedule and Administration

Each Wegovy pen contains a single pre-filled dose administered subcutaneously once weekly, ideally on the same day each week. You can inject into your abdomen, thigh, or upper arm, rotating injection sites to prevent lipodystrophy. The pen uses a hidden needle that automatically retracts, making self-administration straightforward even for needle-averse patients.

The standard dose escalation follows this protocol: 0.25mg weekly for weeks 1-4, 0.5mg weekly for weeks 5-8, 1mg weekly for weeks 9-12, 1.7mg weekly for weeks 13-16, then 2.4mg weekly from week 17 onwards. If you experience persistent gastrointestinal symptoms at any stage, your prescriber may recommend staying at your current dose for an additional four weeks before escalating [1].

Missing a dose requires specific guidance depending on timing. If fewer than five days have passed since your missed dose, take it as soon as you remember. If more than five days have elapsed, skip that dose and resume your normal schedule. Never double doses to compensate. If you miss more than two consecutive doses, contact your prescriber as you may need to restart at a lower dose to avoid severe gastrointestinal reactions.

Storage and Handling Requirements

Unopened Wegovy pens must be refrigerated between 2°C and 8°C until first use. Once you've removed the pen cap for your first injection, you can store the pen at room temperature (up to 30°C) or continue refrigerating it for up to 28 days. Never freeze Wegovy — frozen pens must be discarded even if subsequently thawed. Keep pens in the original carton to protect from light, and ensure the pen cap is replaced after each use. When travelling, use an insulated cool bag with ice packs for journeys exceeding a few hours.

Wegovy Side Effects and Management Strategies

Gastrointestinal symptoms represent the most common side effects, affecting approximately 44% of patients in clinical trials. Nausea typically peaks during the first few weeks after each dose increase and usually subsides within days as your body adjusts [3]. Other frequent reactions include diarrhoea, constipation, vomiting, abdominal pain, and acid reflux. These effects are generally mild to moderate and decrease significantly over time.

Practical management strategies can substantially reduce discomfort. Eat smaller, more frequent meals rather than three large ones. Avoid high-fat, greasy, or spicy foods that exacerbate nausea. Stay well-hydrated, particularly if experiencing vomiting or diarrhoea. Ginger tea or ginger supplements may help settle your stomach. If nausea persists beyond the first month at a given dose, discuss delaying escalation with your prescriber.

Rare but serious side effects require immediate medical attention. Contact your GP or call 111 if you develop severe, persistent abdominal pain that radiates to your back (potential pancreatitis), visual changes, or symptoms of thyroid tumours such as a lump in your neck or persistent hoarseness. Wegovy carries a boxed warning about thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [1][2]. Your prescriber will screen for personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 before prescribing.

Who Can Use Wegovy: Eligibility Criteria

NICE guidelines recommend Wegovy for adults with a BMI of 35 kg/m² or above, or 30 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea [4]. Some prescribers may consider treatment for patients with BMI 27-29.9 kg/m² if significant weight-related health complications exist, though this falls outside standard NICE recommendations.

Wegovy is contraindicated in several circumstances. You cannot use semaglutide if you're pregnant, planning pregnancy, or breastfeeding. It's unsuitable for patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Those with severe gastrointestinal disease, including inflammatory bowel disease or gastroparesis, should avoid Wegovy. Patients with a history of pancreatitis require careful risk-benefit assessment [1][2].

Your UK prescriber will review your complete medical history during the online consultation, including current medications that may interact with semaglutide. Particular attention is paid to insulin and sulfonylurea use, as combining these with Wegovy increases hypoglycaemia risk. The consultation typically takes under three minutes and covers your weight history, previous weight loss attempts, current health conditions, and treatment goals. Subject to prescriber approval, your first prescription can be dispensed the same day.

Lifestyle Modifications for Optimal Results

Wegovy is licensed as an adjunct to reduced-calorie diet and increased physical activity, not as monotherapy. Clinical trial participants received intensive behavioural support including dietary counselling and exercise programmes [3]. Whilst you'll likely lose some weight with Wegovy alone due to appetite suppression, combining medication with sustainable lifestyle changes produces superior long-term outcomes. Aim for a 500-750 calorie daily deficit through portion control and nutrient-dense foods. Incorporate at least 150 minutes of moderate-intensity activity weekly, gradually increasing as your fitness improves and excess weight reduces joint stress.

Ordering Wegovy from Cured Pharmacy: Simple Process

Starting treatment requires just three straightforward steps. First, complete the free online clinical assessment through our secure platform. You'll answer questions about your medical history, current medications, weight loss goals, and any contraindications. The questionnaire takes most patients under three minutes to complete and uses clinical decision-support algorithms to flag any safety concerns.

Second, a UK-registered prescriber reviews your assessment, typically within hours during business days. They may request additional information or suggest alternative treatments if Wegovy isn't suitable for your circumstances. If approved, your prescription is electronically transmitted to our dispensing team. You'll receive confirmation via email and SMS with tracking details.

Third, your medication is dispensed from our GPhC-registered pharmacy and dispatched in 100% discreet packaging with no external branding. We offer next-day delivery across mainland UK, with orders placed before 3pm Monday-Friday typically arriving the following working day. Your first shipment includes the starter dose (0.25mg) along with comprehensive administration instructions and sharps disposal guidance. Subsequent prescriptions can be arranged through your patient account, with automatic reminders before each dose tier needs reordering.

Transparent Pricing and No Hidden Costs

At Cured Pharmacy, you'll see the exact price before completing your consultation — no surprises at checkout. Wegovy starts from £79.00 depending on your prescribed dose, with our lowest price guarantee ensuring you won't find genuine UK-licensed Wegovy cheaper elsewhere. This price includes the medication, clinical consultation, prescription, and standard delivery. We don't charge separate consultation fees or subscription charges. If you're continuing long-term treatment, you can benefit from our multi-month supply options with additional savings. All prices are displayed in pounds sterling, and we accept all major debit and credit cards through our secure payment gateway.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2022). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. Retrieved from https://products.mhra.gov.uk/ [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management [CG189]. NICE. Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.